4.7 Article

Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy

期刊

BLOOD
卷 140, 期 17, 页码 1858-1874

出版社

AMER SOC HEMATOLOGY

关键词

-

资金

  1. Canadian Institutes of Health Research [PJT 178054]
  2. Genome British Columbia [SIP007]
  3. BC Children's Hospital Foundation
  4. Tier 1 Canada Research Chair in Pediatric Precision Health
  5. CIHR Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D)
  6. University of British Columbia Four Year Doctoral Fellowship (4YF)
  7. CGS-D, 4YF, Killam Doctoral Scholarship, Friedman Award for Scholars in Health
  8. BC Children's Hospital Research Institute Graduate Studentship

向作者/读者索取更多资源

The discovery of a human patient with complete deficiency of NFAT1 provides new insights into the pleiotropic role of NFAT1 and the detrimental effects associated with long-term use of calcineurin inhibitors.
The discovery of humans with monogenic disorders has a rich history of generating new insights into biology. Here we report the first human identified with complete deficiency of nuclear factor of activated T cells 1 (NFAT1). NFAT1, encoded by NFATC2, mediates calcium-calcineurin signals that drive cell activation, proliferation, and survival. The patient is homozygous for a damaging germline NFATC2 variant (c.2023_2026delTACC; p.Tyr675Thrfs*18) and presented with joint contractures, osteochondromas, and recurrent B-cell lymphoma. Absence of NFAT1 protein in chondrocytes caused enrichment in prosurvival and inflammatory genes. Systematic single-cell-omic analyses in PBMCs revealed an environment that promotes lymphomagenesis with accumulation of naive B cells (enriched for oncogenic signatures MYC and JAK1), exhausted CD4+ T cells, impaired T follicular helper cells, and aberrant CD8+ T cells. This work highlights the pleiotropic role of human NFAT1, will empower the diagnosis of additional patients with NFAT1 deficiency, and further defines the detrimental effects associated with long-term use of calcineurin inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据